Show simple item record

dc.contributor.authorHill, Nathan
dc.date.accessioned2011-07-13T18:50:34Z
dc.date.available2011-07-13T18:50:34Z
dc.date.issued2011-04-20
dc.identifier.urihttps://hdl.handle.net/1813/23169
dc.description.abstractA six-week-old, 60 kg Holstein bull calf, previously treated at Cornell’s Large Animal Hospital for pneumonia and omphalitis associated with failure of passive transfer (FPT), returned three days later with a primary complaint of lameness. During the course of his hospitalization, the calf underwent an arthrotomy to address septic arthritis in his left stifle. As part of a multimodal approach to pain management, meloxicam was included as adjunctive therapy. Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. Recent research has shown meloxicam to have several potential advantages over flunixin meglumine, the NSAID most commonly used in cattle, including excellent bioavailability following oral administration and a much longer half-life. However, because meloxicam is not labeled for use in food-producing animals, the implications of extra-label drug use must be carefully considered.en_US
dc.language.isoen_USen_US
dc.relation.ispartofseriesSenior seminar paper
dc.relation.ispartofseriesSeminar SF610.1 2011
dc.subjectCattle -- Diseases -- Treatment -- Case studiesen_US
dc.titleUse of meloxicam in a case of septic arthritis and arthrotomy in a six-week old bull calfen_US
dc.typeterm paperen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics